HY-118773-10mg
|
MedChemexpress LLC
|
MreB Perturbing Compound A22 (hydrochloride) [CAS 22816-60-0]
|
|
COVID-19-immunoregulation
|
|
HY-118773-25mg
|
MedChemexpress LLC
|
MreB Perturbing Compound A22 (hydrochloride) [CAS 22816-60-0]
|
|
COVID-19-immunoregulation
|
|
HY-118773-5mg
|
MedChemexpress LLC
|
MreB Perturbing Compound A22 (hydrochloride) [CAS 22816-60-0]
|
|
COVID-19-immunoregulation
|
|
HY-128773A-10mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
HY-128773A-100mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
HY-128773A-25mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
HY-128773A-5mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
HY-128773A-50mg
|
MedChemexpress LLC
|
MRL-494 (hydrochloride) [CAS 2699937-04-5]
|
|
COVID-19-immunoregulation
|
|
HY-18169-10mg
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7]
|
|
COVID-19-immunoregulation
|
|
HY-18169-5mg
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7]
|
|
COVID-19-immunoregulation
|
|
HY-18169-1mL
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-N5127-100mg
|
MedChemexpress LLC
|
Nonacosane [CAS 630-03-5]
|
|
COVID-19-immunoregulation
|
|
HY-N5127-25mg
|
MedChemexpress LLC
|
Nonacosane [CAS 630-03-5]
|
|
COVID-19-immunoregulation
|
|
HY-N5127-50mg
|
MedChemexpress LLC
|
Nonacosane [CAS 630-03-5]
|
|
COVID-19-immunoregulation
|
|
HY-138075-500ug
|
MedChemexpress LLC
|
Obafluorin [CAS 92121-68-1]
|
|
COVID-19-immunoregulation
|
|
HY-N7307-1mg
|
MedChemexpress LLC
|
Pachybasin [CAS 2549-78-2]
|
|
COVID-19-immunoregulation
|
|
HY-125789-1mg
|
MedChemexpress LLC
|
PF-04753299 [CAS 1289620-49-0]
|
|
COVID-19-immunoregulation
|
|
HY-125789-5mg
|
MedChemexpress LLC
|
PF-04753299 [CAS 1289620-49-0]
|
|
COVID-19-immunoregulation
|
|
HY-N1312-100mg
|
MedChemexpress LLC
|
Sinapaldehyde [CAS 4206-58-0]
|
|
COVID-19-immunoregulation
|
|
HY-N1312-250mg
|
MedChemexpress LLC
|
Sinapaldehyde [CAS 4206-58-0]
|
|
COVID-19-immunoregulation
|
|
HY-N1312-50mg
|
MedChemexpress LLC
|
Sinapaldehyde [CAS 4206-58-0]
|
|
COVID-19-immunoregulation
|
|
HY-P2695-1mg
|
MedChemexpress LLC
|
STh [CAS 118447-40-8]
|
|
COVID-19-immunoregulation
|
|
HY-P7294-10ug
|
MedChemexpress LLC
|
TECK/CCL25, Human
|
|
COVID-19-immunoregulation
|
|
HY-P7294-50ug
|
MedChemexpress LLC
|
TECK/CCL25, Human
|
|
COVID-19-immunoregulation
|
|
HY-B0117C-10mg
|
MedChemexpress LLC
|
Tigecycline (tetramesylate)
|
|
COVID-19-immunoregulation
|
|